Literature DB >> 16213135

Transcription inhibition: a potential strategy for cancer therapeutics.

Frederick A Derheimer1, Ching-Wei Chang, Mats Ljungman.   

Abstract

Interference with transcription triggers a stress response leading to the induction of the tumour suppressor p53. If transcription is not restored within a certain time frame cells may undergo apoptosis in a p53-dependent and independent manner. The mechanisms by which blockage of transcription induces apoptosis may involve diminished levels of anti-apoptotic factors, inappropriate accumulation of proteins in the nucleus, accumulation of p53 at mitochondria or complications during replication. Many chemotherapeutic agents currently used in the clinic interfere with transcription and this interference may contribute to their anti-cancer activities. Future efforts should be directed towards exploring whether interference of transcription could be used as an anti-cancer therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213135     DOI: 10.1016/j.ejca.2005.08.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  19 in total

1.  Altered transcription and replication are the mechanisms of cytotoxicity of antitumor antibiotic olivomycin A.

Authors:  I B Cheglakov; A N Tevyashova; L K Kurbatov; V V Tatarsky; A V Samusenko; M N Preobrazhenskaya; A A Shtil
Journal:  Dokl Biochem Biophys       Date:  2010-12-24       Impact factor: 0.788

Review 2.  Connections between 3'-end processing and DNA damage response.

Authors:  Murat A Cevher; Frida E Kleiman
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

3.  RNA polymerase II transcription is required for human papillomavirus type 16 E7- and hydroxyurea-induced centriole overduplication.

Authors:  A Duensing; Y Liu; N Spardy; K Bartoli; M Tseng; J-A Kwon; X Teng; S Duensing
Journal:  Oncogene       Date:  2006-07-03       Impact factor: 9.867

4.  An in vitro enzymatic assay to measure transcription inhibition by gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles.

Authors:  Grace Y Tang; Melanie A Pribisko; Ryan K Henning; Punnajit Lim; John Termini; Harry B Gray; Robert H Grubbs
Journal:  J Vis Exp       Date:  2015-03-18       Impact factor: 1.355

5.  Effects of 6-thioguanine and S6-methylthioguanine on transcription in vitro and in human cells.

Authors:  Changjun You; Xiaoxia Dai; Bifeng Yuan; Yinsheng Wang
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

6.  Antitumor activity of a pyrrole-imidazole polyamide.

Authors:  Fei Yang; Nicholas G Nickols; Benjamin C Li; Georgi K Marinov; Jonathan W Said; Peter B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

7.  A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.

Authors:  Christine M Stellrecht; Mary Ayres; Rishi Arya; Varsha Gandhi
Journal:  Breast Cancer Res Treat       Date:  2009-07-30       Impact factor: 4.872

8.  p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity.

Authors:  Sonja Wolff; Susan Erster; Gustavo Palacios; Ute M Moll
Journal:  Cell Res       Date:  2008-07       Impact factor: 25.617

9.  Trapping of transcription factors with symmetrical DNA using thiol-disulfide exchange chemistry.

Authors:  Markandeswar Panda; Daifeng Jiang; Harry W Jarrett
Journal:  J Chromatogr A       Date:  2008-06-22       Impact factor: 4.759

Review 10.  Inhibition of transcription by platinum antitumor compounds.

Authors:  Ryan C Todd; Stephen J Lippard
Journal:  Metallomics       Date:  2009       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.